Life Science Share News (LABS)

TRADING UPDATES: City Pub revenue up; Real Good Food talks up self-up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

IN BRIEF: Life Science announces new lease at Oxford Technology Park

Life Science REIT PLC - London-based life science property-focused real estate investment trust - Lets out 10,765 square feet across two units at the Innovation Quarter in the Oxford Technology Park to clinical researcher Oxford Gene Technology IP Ltd. Says letting takes all completed space at OTP, let or under offer, to 75%. OTP was acquired by Life Science in May last year.

IN BRIEF: Life Science REIT refinances debt facilities

Life Science REIT PLC - life science property-focused real estate investment trust - Refinances its existing GBP150 million term loan and revolving credit facility, which is secured on its existing portfolio. Says refinanced facilities provided by existing lender HSBC Holdings PLC, with the Bank of Ireland joining the syndicate as an additional lender. The facilities with HSBC and BoI now include GBP100 million fully drawn term loan, increased from GBP75 million, as well as a GBP50 million RCF, with the terms of both extended to March 2026. Additionally, now has GP35 million accordion facility on RCF.

LONDON BROKER RATINGS: Goldman Sachs cuts Great Portland to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

UK shareholder meetings calendar - next 7 days

TRADING UPDATES: Eden Research gets regulatory approval in New Zealand

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

SMALL-CAP WINNERS & LOSERS: PPHE extends Radisson partnership

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

IN BRIEF: Life Science REIT net asset value declines in 2022

Life Science REIT PLC - life science property-focused real estate investment trust - Swings to pretax loss of GBP27.5 million in 2022, from profit of GBP7.7 million in 2021. Gross property income jumps to GBP13.1 million from GBP500,000. However, reports GBP31.3 million fair value loss on investment properties, compared to GBP8.0 million gain in 2021. EPRA net tangible assets per share fall to 90.0 pence from 100.2p. Net asset value per share decreases to 91.3p from 100.2p. "At the end of the group's first full year, I am delighted to say that we have delivered on the promises we set out at our IPO in November 2021. We achieved our goal of fully deploying the IPO proceeds within six months, completed our move from AIM to the Main Market and met our dividend target. Our focus now is on executing our business plans for each of the assets, to drive capital values and income growth whilst embedding rigorous ESG practices in all our operations," Chair Claire Boyle says.

UK earnings, trading statements calendar - next 7 days

Life Science REIT refinances GBP36 million in debt at better rate

(Alliance News) - Life Science REIT PLC on Friday said it has refinanced its existing GBP35.9 million asset-level development debt facility, which was acquired with the company's Oxford Technology Park asset.

Life Science REIT lets Oxford Technology Park office space to Arcturis

(Alliance News) - Life Science REIT PLC on Monday said it agreed a letting of part of the ground floor of Building One at Oxford Technology Park to Arcturis Data Ltd.

Life Science REIT agrees to new lease at Oxford Technology Park

(Sharecast News) - Real estate investment trust Life Science REIT has agreed to a new lease at its Oxford Technology Park with innovative healthcare technology company Arcturis.

Life Science REIT lets second floor of Rolling Stock Yard in London

(Alliance News) - Life Science REIT PLC on Wednesday said it signed an agreement to lease the second floor of its Rolling Stock Yard asset near King's Cross, London, to a life science company backed by Syncona Ltd.